![Andres Gagete](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Andres Gagete
Entité | Type d'entité | Industrie | |
---|---|---|---|
Artax Biopharma, Inc.
![]() Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA.
6
| Holding Company | Medical Specialties | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Andres Gagete via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
GELESIS INC | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Zikani Therapeutics, Inc.
![]() Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | Drugstore Chains | Director of Finance/CFO Chairman | |
ELOXX PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
PIC Therapeutics, Inc.
![]() PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chairman | |
Arrakis Therapeutics, Inc.
![]() Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder | |
AURA BIOSCIENCES, INC. | Biotechnology | Chairman | |
Advent Venture Partners LLP
![]() Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Valerion Therapeutics LLC
![]() Valerion Therapeutics LLC Medical SpecialtiesHealth Technology Valerion Therapeutics LLC develops targeted therapies for orphan genetic diseases. The firm utilizes a proprietary antibody-mediated delivery platform to target therapies to specific tissues via a studied transport pathway. It therapies are based on an intracellular delivery technology platform that takes advantage of tissue targeting via an antibody and intracellular delivery dependent on membrane expression of a nucleoside transporter. The company was founded by Timothy S. Harris and Dustin D. Armstrong in 2007 and is headquartered in Concord, MA. | Medical Specialties | Director/Board Member | |
Sanofi Ventures
![]() Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Chief Investment Officer | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Arcturus Studios Holdings, Inc.
![]() Arcturus Studios Holdings, Inc. Packaged SoftwareTechnology Services Arcturus Studios Holdings, Inc. specializes in editing and compressing volumetric video through their holostream and holosuite products. Arcturus Studios Holdings is based in Beverly Hills, CA and has subsidiaries in Canada. These products provide adaptive streaming volumetric video for uninterrupted experiences delivered on demand. The company has received positive feedback from clients such as Crescent Studios, Far East Company, Inc., and NTT Docomo, Inc. for their professional-grade tools and ability to anticipate customer needs. Holoedit and holosuite have been used in various projects, including those featuring BTS and the 2019 Samsung Developer Conference. The company was founded by Devin Horsman, Andy Stack, and Ewan Johnson, and the CEO is Kamal Mistry. | Packaged Software | Director/Board Member | |
ATEA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Termeer Foundation | Founder | ||
ELICIO THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
CALCIMEDICA, INC. | Biotechnology | Director of Finance/CFO | |
Promedior, Inc.
![]() Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Medical Specialties | Director of Finance/CFO | |
EDITAS MEDICINE, INC. | Biotechnology | Director of Finance/CFO | |
OPY ACQUISITION CORP. I | Financial Conglomerates | Director of Finance/CFO | |
Myeloid Therapeutics, Inc.
![]() Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO | |
VAXXINITY, INC. | Biotechnology | Director of Finance/CFO | |
CalciMedica, Inc. (US)
![]() CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Biotechnology | Director of Finance/CFO | |
Nemucore Medical Innovations, Inc.
![]() Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Advent Life Sciences LLP
![]() Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry. | Biotechnology | Corporate Officer/Principal | |
Neuroelectrics, Inc.
![]() Neuroelectrics, Inc. Miscellaneous Commercial ServicesCommercial Services Neuroelectrics, Inc. is a company that is developing a therapeutic platform for the treatment of neurological and psychiatric disorders. The company is based in Cambridge, MA and Barcelona, Spain. The company's platform uses neuromodulation, which combines safe and proven neuromodulation capabilities with remote-controlled delivery and personalized treatment protocols to restore and maintain brain health. Neuroelectrics has an expanding pipeline of computationally driven solutions for neurologic and psychiatric disorders. The company was founded by Ana Maiques Valls and Giulio Ruffini, and Ana Maiques Valls has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Antolrx, Inc.
![]() Antolrx, Inc. BiotechnologyHealth Technology Antolrx, Inc. operates in the healthcare industry focusing on biotechnology business. The company was founded by Mark Carthy and is headquartered in Boston, MA. | Biotechnology | Director of Finance/CFO | |
Mogen International Nv
![]() Mogen International Nv Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Mogen International Nv is a Dutch company that specializes in medicinal chemicals and botanical products. The company is based in Leiden, the Netherlands. Mogen International was acquired by Zeneca Group Plc on May 01, 1997 for $74.96 million. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Sanifit Therapeutics SA
![]() Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Biotechnology | Director/Board Member | |
Tyris Therapeutics SL
![]() Tyris Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Tyris Therapeutics SL provides business management consulting services. The company is based in Valencia, Spain. The Spanish company was founded in 2020. The CEO is Carulla Damià Tormo. | Miscellaneous Commercial Services | Chief Executive Officer | |
Highlight Therapeutics SL
![]() Highlight Therapeutics SL Pharmaceuticals: MajorHealth Technology Highlight Therapeutics develops ribonucleic acid-based therapies and novel targets in cancer and immune cells. Its product BO-112, induces immunogenic cell death in solid tumors and simultaneously activates the innate immune system to ensure optimal antigen processing and presentation to the adaptive immune system. The company was founded by Damia tormo Carulla and is headquartered in Paterna, Spain. | Pharmaceuticals: Major | Founder | |
Columbus Venture Partners SGEIC SA
![]() Columbus Venture Partners SGEIC SA Investment ManagersFinance Columbus Venture Partners SGEIC SA (Columbus VP) is an independent Spanish venture capital firm which was founded in 2015 by Javier García Cogorro and Damià Tormo Carulla. The firm headquartered in Madri, Spain. | Investment Managers | Founder | |
Sapreme Technologies BV
![]() Sapreme Technologies BV BiotechnologyHealth Technology Sapreme Technologies BV operates as a biotech company that develops a platform technology to enable cytosolic delivery of macromolecule therapeutics. The company was founded by Ruben Postel in 2016 and is headquartered in Utrecht, the Netherlands. | Biotechnology | Director/Board Member | |
Fibrocor Therapeutics LP
![]() Fibrocor Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Fibrocor Therapeutics LP is a privately held Canadian drug discovery company that is pioneering the use of tissue-specific therapeutics in the field of precision medicine, particularly in fibrosis. The company is based in Toronto, Canada. The company aims to improve the lives of patients by delivering transformative treatments that tackle the root causes of fibrosis, leading to better outcomes and enhanced quality of life. Fibrocor leverages its extensive expertise and one of the largest patient-derived clinically annotated biorepositories of fibrotic tissue to refine and validate therapeutic candidates, ensuring they meet the highest standards of efficacy and safety. | Miscellaneous Commercial Services | Director/Board Member | |
Syngenta Mogen BV | Corporate Officer/Principal | ||
Mimetas BV
![]() Mimetas BV BiotechnologyHealth Technology Mimetas BV develops organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models. It develops microfluidics-based culture plates that enable culturing and screening of a range of 3D organ and tissue models. The firm offers OrganoPlates microfluidics-based culture plates that serve as early stage screening models predicting toxic side effects and drug efficacy. The company was founded by Paul Vulto and Jos Joore in 2013 and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member | |
VitalneXt BV
![]() VitalneXt BV Pharmaceuticals: GenericHealth Technology VitalneXt BV develops retails and manufactures products for healthy ageing. Its products include promanna, vital01 and other products. The firm develops products with evidence-based health benefits for the ageing population. It also develops new, proprietary, technologies, ingredients and products through its own network and through collaborations with the company's research partners. The company was founded by Rein Strijker in May 2013 and is headquartered in Amersfoort, the Netherlands. | Pharmaceuticals: Generic | Director/Board Member | |
University of Leiden | College/University | Doctorate Degree | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
DSM Life Sciences Products | Corporate Officer/Principal | ||
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Molecular Probes Europe BV | Chief Executive Officer | ||
GALAPAGOS NV | Biotechnology | Corporate Officer/Principal | |
Minden Exchange Bank & Trust Co.
![]() Minden Exchange Bank & Trust Co. Regional BanksFinance Minden Exchange Bank & Trust Co. operates as a state chartered commercial bank. Its services include automated teller machine and debit cards, online and mobile banking, exchange bill pay, trust services, direct deposit, notary services, night deposit, coin counting, wire, automatic and telephone transfers, and cashiers check. It offers checking, savings, money market, loans, certificates of deposit, and individual retirement account. The company was founded in September 1, 1883 and is headquartered in Minden, NE. | Regional Banks | President |
Statistiques
Internationale
Etats-Unis | 34 |
Pays-Bas | 10 |
Espagne | 5 |
Royaume-Uni | 3 |
Canada | 2 |
Sectorielle
Health Technology | 33 |
Finance | 8 |
Commercial Services | 4 |
Retail Trade | 2 |
Technology Services | 2 |
Opérationnelle
Director/Board Member | 48 |
Director of Finance/CFO | 41 |
Independent Dir/Board Member | 15 |
Corporate Officer/Principal | 14 |
Chairman | 9 |
Relations les plus connectées
Insiders | |
---|---|
Daniel Geffken | 53 |
Gino Santini | 26 |
Alan Walts | 17 |
Andre Hoekema | 14 |
Rob W. Armstrong | 13 |
Carulla Tormo | 6 |
- Bourse
- Insiders
- Andres Gagete
- Connexions Sociétés